HS
ARIA

HighVista Strategies’s Ariad Pharmaceuticals Inc ARIA Stock Holding History

HighVista Strategies’s Portfolio ARIA Stock Details ARIA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-638,086
Closed -$7.94M – 202
2016
Q4 		$7.94M Hold
638,086
– – 1.56% 17
2016
Q3 		$8.73M Sell
638,086
-231,014
-27% -$2.32M 1.62% 17
2016
Q2 		$6.42M Buy
869,100
+62,000
+8% +$465K 1.23% 19
2016
Q1 		$5.16M Hold
807,100
– – 0.97% 23
2015
Q4 		$5.04M Sell
807,100
-42,900
-5% -$282K 0.94% 20
2015
Q3 		$4.96M Sell
850,000
-350,000
-29% -$2.7M 0.94% 25
2015
Q2 		$9.92M Hold
1,200,000
– – 1.69% 12
2015
Q1 		$9.89M Hold
1,200,000
– – 1.58% 11
2014
Q4 		$8.24M Hold
1,200,000
– – 1.08% 15
2014
Q3 		$6.48M Buy
+1,200,000
New +$7.01M 0.87% 20

Other funds holding ARIA

FPF
FNY Partners Fund New York $185M AUM 32.59% 1-Year Est. Return

HighVista Strategies's ARIA Position: Q1 2017 in Review

HighVista Strategies sold out of Ariad Pharmaceuticals Inc (ARIA) in Q1 2017, closing a stake of 638,086 shares — an estimated $7.94M sold.

HighVista Strategies first reported a position in ARIA in Q3 2014 and held it in 10 quarters. The position peaked at $9.92M in Q2 2015. 1 fund tracked by Wall St. Rank holds ARIA as of Q1 2017.

  • HighVista Strategies reported no remaining Ariad Pharmaceuticals Inc position as of Q1 2017 after selling out during the quarter.
  • HighVista Strategies sold 638,086 Ariad Pharmaceuticals Inc shares in Q1 2017, an estimated $7.94M.
  • HighVista Strategies first reported a position in Ariad Pharmaceuticals Inc in Q3 2014 and held it in 10 quarters.
  • HighVista Strategies's Ariad Pharmaceuticals Inc position peaked at $9.92M in Q2 2015.
  • 1 fund tracked by Wall St. Rank held Ariad Pharmaceuticals Inc as of Q1 2017.

Based on HighVista Strategies's 13F filing for Q1 2017, filed 15 May 2017.